Has Dinesh Arab, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,231,088 in general payments to Dinesh Arab, MD across 1,112 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dinesh Arab, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dinesh Arab, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dinesh Arab, MD

Cardiovascular Disease · Daytona Beach, FLNPI 1902843303

Payments from drug & device makers

$1,231,088in general payments, 2019–2025

Across 1,112 payments — averaging $1107.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Research & Development, LLC$401K
Amgen$343K
Novartis$232K
Medtronic$70K
Boehringer Ingelheim International GmbH$64K
Boehringer Ingelheim Pharma GmbH & Co.kg$38K
plus $83K from 52 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Research & Development, LLC	38	$400,827
Amgen	37	$342,688
Novartis	37	$232,325
Medtronic(2 entities)	229	$69,537
Boehringer Ingelheim International GmbH	74	$64,451
Boehringer Ingelheim Pharma GmbH & Co.kg	9	$38,179
Bayer	7	$20,815
Cardiovascular Systems Inc.	62	$10,937
CSL Behring	4	$9,956
Daiichi Sankyo Inc.	12	$8,635
Cvrx, Inc.	79	$8,085
AstraZeneca	10	$6,337
Abbott	69	$6,131
Edwards Lifesciences	46	$2,721
Boston Scientific	25	$1,841
Johnson & Johnson(2 entities)	101	$1,122
Boehringer Ingelheim	41	$1,009
Abiomed	17	$889
Astellas Pharma US Inc	7	$514
Pfizer	35	$475
Merck	20	$425
Sanofi-aventis U.S. LLC	20	$378
E.r. Squibb & Sons, L.L.C.	29	$294
Penumbra, Inc.	4	$290
Amarin Pharma, Inc.	14	$246
Atricure, Inc.	10	$238
Kestra Medical Technology Services, Inc.	6	$178
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	8	$135
Inari Medical, Inc.	2	$125
Philips North America LLC	4	$124
Livanova USA, Inc.	3	$116
Impulse Dynamics (USA) Inc.	5	$96
Kowa Pharmaceuticals America, Inc.	7	$94
Esperion Therapeutics, Inc.	4	$76
Novo Nordisk	5	$71
Irhythm Technologies, Inc.	4	$67
United Therapeutics Corporation	2	$62
Arineta, Inc	1	$60
Opsens Inc.	1	$50
Biotronik Inc.	2	$47
Angiodynamics, Inc.	2	$46
Cleerly, Inc.	1	$45
Arbor Pharmaceuticals, Inc.	1	$34
Gilead	2	$30
ZOLL Circulation Inc	2	$29
Biosense Webster, Inc.	1	$29
Alnylam Pharmaceuticals Inc.	1	$28
Heartflow, Inc.	1	$28
Acist Medical Systems, Inc.	1	$26
Braemar Manufacturing, LLC	1	$25
Bardy Diagnostics, Inc.	2	$23
Altathera Pharmaceuticals LLC	1	$18
Bsn Medical Inc	1	$16
Teleflex LLC	1	$15
Siemens Medical Solutions USA, Inc.	1	$14
Terumo Medical Corporation	1	$13
G Medical Diagnostic Services, Inc.	1	$12
W. L. Gore & Associates, Inc.	1	$12

How this compares

$1,231,088 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida →

Medicare billing

Part B allowed, 2024

$1,763,829

Medicare patients

2,239

Services billed

11,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Daytona Beach

David HendersonDaytona Beach$1.8M
Michael KorenGainesville$31M
Seth BaumBoca Raton$11.1M
Alexis GutierrezHialeah$8M
Eric SpivackAventura$7.1M
William OneillNaples$4.6M
Rafik AbadierInverness$4.4M
Alvaro MurciaPembroke Pines$4M
David HotchkissPort Charlotte$4M
Ferris GeorgeSt Augustine$3.8M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →